SIGA Technologies Inc (SIGA)
6.96
+0.02
(+0.29%)
USD |
NASDAQ |
Sep 27, 16:00
6.94
-0.02
(-0.29%)
After-Hours: 20:00
SIGA Technologies SG&A Expense (Annual): 22.04M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 22.04M |
December 31, 2022 | 35.12M |
December 31, 2021 | 18.03M |
December 31, 2020 | 14.72M |
December 31, 2019 | 13.25M |
December 31, 2018 | 12.88M |
December 31, 2017 | 12.30M |
December 31, 2016 | 13.71M |
December 31, 2015 | 10.58M |
December 31, 2014 | 12.65M |
December 31, 2013 | 13.12M |
December 31, 2012 | 10.97M |
December 31, 2011 | 23.93M |
December 31, 2010 | 8.131M |
Date | Value |
---|---|
December 31, 2009 | 8.267M |
December 31, 2008 | 5.190M |
December 31, 2007 | 4.219M |
December 31, 2006 | 4.919M |
December 31, 2005 | 2.714M |
December 31, 2004 | 4.435M |
December 31, 2003 | 2.947M |
December 31, 2002 | 1.943M |
December 31, 2001 | 2.571M |
December 31, 2000 | 4.958M |
December 31, 1999 | 2.30M |
December 31, 1998 | 2.80M |
December 31, 1997 | 1.60M |
December 31, 1996 | 0.80M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
13.25M
Minimum
2019
35.12M
Maximum
2022
20.63M
Average
18.03M
Median
2021
SG&A Expense (Annual) Benchmarks
Emergent BioSolutions Inc | 368.40M |
Chimerix Inc | 24.60M |
Geovax Labs Inc | 6.022M |
Abbott Laboratories | 10.95B |
Tonix Pharmaceuticals Holding Corp | 34.75M |